Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel
LON:HLN

Haleon Interim Earnings Report

Haleon logo
GBX 364.30 +3.90 (+1.08%)
As of 07/3/2026 12:19 PM Eastern
ProfileEarnings HistoryForecast

Haleon EPS Results

Actual EPS
GBX 8.90
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Haleon Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Haleon Announcement Details

Quarter
Interim
Date
7/31/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Haleon Earnings Headlines

Haleon PLC (HLN) Gets a Sell from Deutsche Bank
July 3 at 1:01 AM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/3104445/haleon-plc-hln-gets-a-sell-from-deutsche-bank/
Haleon CFO Dawn Allen Receives Performance Share Award and Sells Portion to Cover Taxes
July 2 at 9:51 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/haleon-cfo-dawn-allen-receives-performance-share-award-and-sells-portion-to-cover-taxes?utm_source=marketbeat.com&utm_medium=referral
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
 |  Profits Run (Ad)
Haleon updates market on total voting rights and share capital
July 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/haleon-updates-market-on-total-voting-rights-and-share-capital?utm_source=marketbeat.com&utm_medium=referral
Futura swaps Haleon for Market Performance Group to drive US Eroxon sales - UPDATE
June 29, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/futura-swaps-haleon-market-performance-062400123.html
J.P. Morgan Reaffirms Their Sell Rating on Haleon PLC (HLN)
June 28, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/HLN-N/pressreleases/3007713/j-p-morgan-reaffirms-their-sell-rating-on-haleon-plc-hln/
See More Haleon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Haleon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Haleon and other key companies, straight to your email.

About Haleon

Haleon (LON:HLN) (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

View Haleon Profile
Earnings Tools